From: The dual role of diabetes on oral potentially malignant disorders
Analysis | Exposure | Outcome | Heterogeneity statistics | Horizontal pleiotropy | |||
---|---|---|---|---|---|---|---|
Cochran's Q | I2 | P | Egger intercept | P | |||
Before correction | T1D | AC | 47.057 | 0.384 | 0.018 | − 0.005 | 0.440 |
 |  | OLK | 49.023 | 0.408 | 0.011 | − 0.003 | 0.860 |
 |  | OLP | 84.212 | 0.656 | 0.000 | 0.004 | 0.745 |
 | T2D | AC | 152.565 | 0.364 | 0.000 | − 0.010 | 0.093 |
 |  | OLK | 111.670 | 0.131 | 0.146 | − 0.012 | 0.250 |
 |  | OLP | 231.559 | 0.581 | 0.000 | − 0.001 | 0.886 |
 | HbA1c | AC | 119.897 | 0.491 | 0.000 | − 0.003 | 0.605 |
 |  | OLK | 84.885 | 0.281 | 0.023 | − 0.005 | 0.599 |
 |  | OLP | 104.569 | 0.417 | 0.000 | − 0.001 | 0.842 |
 | FG | AC | 77.627 | 0.291 | 0.024 | − 0.003 | 0.501 |
 |  | OLK | 66.458 | 0.172 | 0.138 | − 0.002 | 0.819 |
 |  | OLP | 63.997 | 0.141 | 0.190 | 0.012 | 0.040 |
 | FI | AC | 25.739 | 0.088 | 0.587 | − 0.002 | 0.813 |
 |  | OLK | 32.819 | 0.147 | 0.242 | 0.030 | 0.144 |
 |  | OLP | 42.636 | 0.343 | 0.038 | − 0.028 | 0.053 |
After correction | T1D | AC | 21.682 | 0.107 | 0.598 | − 0.005 | 0.355 |
 |  | OLK | 19.860 | 0.309 | 0.798 | 0.015 | 0.186 |
 |  | OLP | 25.652 | 0.103 | 0.318 | 0.010 | 0.212 |
 | T2D | AC | 76.829 | 0.132 | 0.774 | − 0.007 | 0.140 |
 |  | OLK | 76.005 | 0.184 | 0.854 | − 0.003 | 0.790 |
 |  | OLP | 86.211 | 0.021 | 0.534 | − 0.008 | 0.209 |
 | HbA1c | AC | 46.329 | 0.122 | 0.696 | − 0.008 | 0.066 |
 |  | OLK | 36.167 | 0.465 | 0.963 | 0.001 | 0.877 |
 |  | OLP | 55.676 | 0.030 | 0.412 | 0.006 | 0.308 |
 | FG | AC | 38.215 | 0.361 | 0.923 | 0.000 | 0.977 |
 |  | OLK | 45.194 | 0.128 | 0.702 | − 0.007 | 0.411 |
 |  | OLP | 51.241 | 0.034 | 0.543 | 0.013 | 0.023 |
 | FI | AC | 17.110 | 0.520 | 0.906 | 0.003 | 0.765 |
 |  | OLK | 24.148 | 0.118 | 0.622 | 0.022 | 0.260 |
 |  | OLP | 23.264 | 0.032 | 0.504 | − 0.018 | 0.170 |